Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer

Clinicaltrials.gov ID: NCT06326216
db-list-check Status RECRUITING
b-loader Phase
b-people Age ≥ 18 Years
b-bullseye-arrow Enrollments 100

Conditions

Prostate Carcinoma

Summary

This study is being done to determine whether levels of prostate cancer derived extracellular vesicles from blood and urine specimens correlate with response to primary local treatment (surgery) in prostate cancer.

Detailed Description

PRIMARY OBJECTIVES:

I. Determine the levels of prostate cancer-derived extracellular vesicles pre- and post-radical prostatectomy.

II. Determine the correlation between levels of prostate cancer-derived extracellular vesicles and PSA.

OUTLINE: This is an observational study. Participants are assigned to 1 of 2 cohorts.

COHORT I: Prostate cancer patients undergo blood and urine sample collection on study. Patients’ medical records are also reviewed.

COHORT II: Female urology clinic patients and female volunteers undergo blood and urine sample collection on study.

Locations

1 location Found with status Recruiting

Status

  • RECRUITING

Contact Person

Principal Investigator

  • Eugene D. Kwon, M.D.

Eligibility Criteria

Inclusion Criteria:

* * PROSTATE CANCER PATIENTS:

* Age 18+
* Able to give informed consent
* Patients with prostate cancer
* Patients treated with primary prostatectomy

* The focus will be on high-risk patients with at least one of either criterion:
* PSA >= 20 ng/ml
* AND/OR Gleason >= 8
* AND/OR clinical stage >= T3
* * FEMALE CONTROL PATIENTS:

* Age 18+
* Able to give informed consent

Exclusion Criteria:

* * PROSTATE CANCER PATIENTS:

* Unable or unwilling to provide informed consent
* Metastatic prostate cancer - defined evidence of metastatic disease on pre-procedural testing
* * FEMALE CONTROL PATIENTS:

* Unable or unwilling to provide informed consent

Study Plan

Observational (Cohort I)

Prostate cancer patients undergo blood and urine sample collection on study. Patients' medical records are also reviewed.

  • OTHER:

    Non-Interventional Study

    Description:

    Non-interventional study

Observational (Cohort II)

Female urology clinic patients and female volunteers undergo blood and urine sample collection on study.

  • OTHER:

    Non-Interventional Study

    Description:

    Non-interventional study

Outcome Measures

Primary Outcome Measures

Levels of prostate cancer-derived extracellular vesicles (EVs) - radical prostatectomy

Time Frame: Pre-surgery; once post-surgery, 6 weeks to 6 months after surgery (likely collected during routine visits); annual blood collection until (optional)

Levels of prostate cancer-derived extracellular vesicles (EVs) - negative controls

Time Frame: Baseline

Correlation between prostate specific antigen (PSA) levels and prostate cancer-derived EVs

Time Frame: Baseline

Prostate cancer-derived EV levels

Time Frame: Baseline

Timeline

  • Last Updated
    August 12, 2024
  • Start Date
    March 22, 2024
  • Today
    January 16, 2025
  • Completion Date ( Estimated )
    July 1, 2025

Similar Trials

light-list-check RECRUITING light-blue-people 21 - 64 Years
light-list-check RECRUITING light-blue-people ≥ 18 Years
light-list-check RECRUITING light-blue-people ≥ 65 Years